Rationale and strategies for chemoprevention of cancer in humans.
about
Lung cancer. 1: prevention of lung cancerGarlic and its significance for the prevention of cancer in humans: a critical viewEffects of Maharishi Amrit Kalash 5 as an Ayurvedic herbal food supplement on immune functions in aged mice.Recruitment for the beta-carotene and retinol efficacy trial (CARET) to prevent lung cancer in smokers and asbestos-exposed workers.APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functionsInvertebrates in testing of environmental chemicals: are they alternatives?Pharmacologic approaches to protection against radiation-induced lethality and other damage.Dietary modifiers of carcinogenesisChemicals and cancer in humans: first evidence in experimental animals.Nasal cytology in southwest metropolitan Mexico City inhabitants: a pilot intervention study.The carcinogenesis bioassay in perspective: application in identifying human cancer hazards.Modulating factors in the expression of radiation-induced oncogenic transformation.Assessing toxicity in cancer chemoprevention trials: the other side of the coinEndogenous oxidative damage of deoxycytidine in DNA.Cancer Prevention: Obstacles, Challenges and the Road Ahead.Sarcophine-diol, a Chemopreventive Agent of Skin Cancer, Inhibits Cell Growth and Induces Apoptosis through Extrinsic Pathway in Human Epidermoid Carcinoma A431 CellsRetinol, vitamins, and cancer prevention: 25 years of learning and relearning.Introduction: Cancer chemoprevention and its context.Vitamin A/retinol and maintenance of pluripotency of stem cells.Proliferation and differentiation biomarkers in colorectal mucosa and their application to chemoprevention studiesAuraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes.Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.
P2860
Q24678926-FA398F8A-849C-468A-8856-E62F5DC8C959Q24685874-97E6ED60-8178-4945-BE0E-385A083A919EQ24805931-B56FFA91-D6B2-45CC-A9B0-798701F90951Q33560251-535E1FA3-217A-40DA-97C0-3DA8C557A39DQ33990581-5790F249-C951-4C82-B327-EF480E1783C5Q34469158-4E636F89-81AB-4967-B432-02E3CB206F96Q34638214-CE49D84C-BE09-44A2-880C-BF80B31FDD11Q34833864-BA96D608-785F-462C-A14F-4AA9A04285BAQ34843586-7524EBB4-C348-41EA-B7EB-EEB4DE60137AQ34846173-CBC63E36-FCAA-4B4C-8D57-E56A63721A0EQ34864407-15F80053-76FE-4020-86FC-BDE8C498BBC5Q35034011-F0986FDB-EDC6-4A8D-BEB3-E7A131CE8F5DQ36359593-73427017-D1EB-4497-A850-BB2A30AECA80Q36951566-4F827D13-729D-47FB-94D2-27CC78DCC5E1Q37002946-1197B759-AA10-4B13-B6B8-D5FB66A9D5FCQ37109455-0D1AA98B-E2AF-4D6B-9C12-352112C05F43Q37141610-736405C0-FADE-4B26-B358-4037BD1E9C07Q37514273-2CE7D939-ABD4-4BB8-B4E9-C5F2966A278BQ37666887-732E007F-7B01-4C45-9331-2954E4DF72E6Q40820062-52548DBE-2FF0-42BA-B196-040555889BD4Q41111421-719BB93E-33FB-4269-A812-6B5EE563525AQ42773874-3D74B74C-2B3F-43EB-BD6D-89CAB996601D
P2860
Rationale and strategies for chemoprevention of cancer in humans.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Rationale and strategies for chemoprevention of cancer in humans.
@en
Rationale and strategies for chemoprevention of cancer in humans.
@nl
type
label
Rationale and strategies for chemoprevention of cancer in humans.
@en
Rationale and strategies for chemoprevention of cancer in humans.
@nl
prefLabel
Rationale and strategies for chemoprevention of cancer in humans.
@en
Rationale and strategies for chemoprevention of cancer in humans.
@nl
P2093
P1433
P1476
Rationale and strategies for chemoprevention of cancer in humans
@en
P2093
Bertram JS
Kolonel LN
Meyskens FL Jr
P304
P407
P577
1987-06-01T00:00:00Z